홈 > 시장보고서 > 의약품 > 신경질환

시장보고서

상품코드

1635891

헌팅턴병 치료 시장 보고서 : 유형별, 약물 유형별, 연령별, 유통 채널별, 최종사용자별, 지역별(2025-2033년)

Huntington´s Disease Treatment Market Report by Type, Drug Type, Age, Distribution Channel, End User, and Region 2025-2033

발행일: 2025년 01월 | 리서치사:

IMARC | 페이지 정보: 영문 133 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

헌팅턴병 치료 시장 세계 시장 규모는 2024년 5억 7,890만 달러에 달했습니다. 향후 IMARC Group은 시장이 2033년까지 24억 4,300만 달러에 달할 것으로 예상하며, 2025년부터 2033년까지 17.4%의 연평균 성장률(CAGR)을 보일 것으로 예측하고 있습니다. 헌팅턴병의 주요 동향의 증가, 첨단 치료제에 대한 수요 증가, 혁신적인 치료 접근법의 최근 개발은 시장을 주도하는 중요한 요인 중 하나입니다.

헌팅턴병은 뇌 신경세포의 파괴가 진행되는 치명적인 신경 퇴행성 질환입니다. 헌팅턴병의 증상으로는 불수의적 운동, 근력장애, 정리 및 집중력 장애, 의식장애, 불면증, 사회적 은둔 등 다양한 운동장애, 정신장애, 인지장애 등이 있습니다. 헌팅턴병 치료에는 항정신병약, 항우울제, 항파킨슨병약, 항우울제, 기분안정제 등 다양한 약물이 사용됩니다. 치료 과정에는 언어치료, 작업치료, 물리치료, 심리치료 등 다양한 치료도 포함됩니다. 헌팅턴병 치료는 운동장애와 정신장애의 증상을 최소화하고, 환자가 단기간에 새로운 능력에 적응할 수 있도록 돕고, 대처전략을 개발하도록 돕습니다. 또한 일상적인 작업과 말하기, 자세와 균형 유지, 삶의 질 향상에도 도움이 됩니다.

헌팅턴병 치료 시장 동향:

전 세계적으로 헌팅턴병의 유병률이 증가하고 있는 것이 시장 성장을 촉진하는 주요 요인 중 하나입니다. 헌팅턴병 치료는 비자발적 운동 및 움직임 억제, 무도병 치료, 폭력적 폭발 및 흥분 억제, 근력, 유연성, 균형, 협응력 강화 등에 널리 사용되고 있으며, 그 결과 삶의 질이 향상되고 식사, 의사소통, 보행과 같은 일상적인 루틴 작업을 수행하는 환자의 능력이 강화됩니다. 강화됩니다. 또한, 헌팅턴병의 운동, 인지, 정신 증상을 조절하는 첨단 약물에 대한 수요 증가가 시장 성장의 원동력이 되고 있습니다. 이에 따라 헌팅턴병과 그 근본적인 원인에 대한 이해가 깊어지고, 새로운 질병 변형 약물의 개발이 빠르게 진행되고 있는 것도 성장을 촉진하는 요인으로 작용하고 있습니다. 또한, 변이형 헌팅턴병(mTT) 생산 수준을 낮춤으로써 헌팅턴병의 성장을 억제하는 혁신적인 치료 접근법의 최근 동향은 시장에 긍정적인 영향을 미치고 있습니다. 이와는 별도로, 헌팅턴(HTT) 메신저 리보핵산(mRNA)과 중추신경계(CNS) 전체에서 해당 단백질을 표적으로 하는 안티센스 올리고뉴클레오티드(ASO)를 사용하는 안티센스 기술의 도입은 시장 성장을 촉진하고 있습니다. 또한, 여러 정부의 신약 개발 촉진에 대한 노력이 활발해지고 있는 것도 시장 개척에 힘을 실어주고 있습니다. 그 외, 헌팅턴병에 대한 대중의 인식 증가, 헬스케어 산업의 괄목할 만한 성장, 연구개발(R&D) 활동에 대한 투자 증가, 노령 인구 증가, 적응증 외 치료제에 대한 수요 증가 등이 시장 성장을 촉진할 것으로 예상됩니다.

본 보고서에서 다루는 주요 질문

2024년 세계 헌팅턴병 치료 시장 규모는?
2025-2033년 세계 헌팅턴병 치료 시장의 예상 성장률은?
세계 헌팅턴병 치료 시장을 이끄는 주요 요인은 무엇인가?
COVID-19가 세계 헌팅턴병 치료 시장에 미치는 영향은?
전 세계 헌팅턴병 치료 시장의 유형별 분류는?
전 세계 헌팅턴병 치료 시장의 약물 유형별 분류는?
전 세계 헌팅턴병 치료 시장의 연령별 분석은?
전 세계 헌팅턴병 치료 시장의 유통 채널별 분포는?
세계 헌팅턴병 치료 시장의 주요 지역은?
세계 헌팅턴병 치료 시장의 주요 플레이어/기업은?

The global Huntington's disease treatment market size reached USD 578.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,443 Million by 2033, exhibiting a growth rate (CAGR) of 17.4% during 2025-2033. The rising incidences of Huntington's disease, the increasing demand for advanced drugs for the disease treatment, and recent development of innovative therapeutic approaches represent some of the key factors driving the market.

Huntington's disease refers to a fatal neurodegenerative disorder that causes the progressive breakdown of nerve cells in the brain. Its symptoms include various movement, psychiatric, and cognitive impairments, such as involuntary jerking, muscle problems, difficulty in organizing and focusing, lack of awareness, insomnia, and social withdrawal. Huntington's disease treatment involves the application of various drugs, such as antipsychotics, antidepressants, antiparkinsonians, and mood-stabilizing drugs. The treatment process also includes various therapies, such as speech, occupational, physical, and psychotherapy. Huntington's disease treatment helps in minimizing the symptoms of movement and psychiatric disorders, assists patients in adapting to new abilities in a shorter time, and develops coping strategies. It also aids in improving everyday tasks, speech, maintaining posture and balance, and enhancing the quality of life.

Huntington's Disease Treatment Market Trends:

The rising incidence of Huntington's disease across the globe is one of the primary factors driving the market growth. Huntington's disease treatment is widely used to suppress involuntary jerking and writhing movement, treat chorea, reduce violent outbursts and agitation, and enhance strength, flexibility, balance, and coordination, which, in turn, improves the quality of life and enhances the patient's ability to carry out daily routine tasks, such as eating, communications, and walking. Furthermore, the increasing demand for advanced drugs to control the motor, cognitive, and psychiatric symptoms associated with Huntington's disease is providing an impetus to the market growth. In line with this, the rapid development of new disease-modifying drugs owing to the improved understanding of the disease, and its underlying causes are acting as another growth-inducing factor. Additionally, the recent development of the innovative therapeutic approach that deters the growth of Huntington's disease by reducing mutant huntingtin (mTT) production levels is positively influencing the market. Apart from this, the introduction of antisense technology that uses antisense oligonucleotides (ASOs) to target huntingtin (HTT) messenger ribonucleic acid (mRNA) and its protein throughout the central nervous system (CNS) is propelling the market growth. Moreover, increasing initiatives by several governments to promote the development of novel drugs are favoring the market growth. Other factors, including rising awareness among the masses regarding Huntington's disease, significant growth in the healthcare industry, increasing investment in research and development (R&D) activities, rising geriatric population, and escalating demand for off-label medications, are anticipated to drive the market growth.

Key Market Segmentation:

Type Insights:

Symptomatic Treatment
Disease-modifying Therapies
The report has also provided a detailed breakup and analysis of the Huntington's disease treatment market based on the type. This includes symptomatic treatment and disease-modifying therapies. According to the report, symptomatic treatment represented the largest segment.

Drug Type Insights:

Approved Drugs
Tetrabenazine
Deutetrabenazine
Off-label Drugs

Age Insights:

Below 50 Years
Above 50 Years

Distribution Channel Insights:

Drug Stores and Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

End User Insights:

Hospitals
Homecare
Specialty Clinics
Others

Regional Insights:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for Huntington's disease treatment. Some of the factors driving the North America Huntington's disease treatment market includes significant technological advancements, the rapid development of healthcare infrastructure, and the rising number of individuals suffering from Huntington's disease.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global Huntington's disease treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AOP Health, Apotex Inc., Dr. Reddy's Laboratories Ltd., H. Lundbeck A/S, Hikma Pharmaceuticals PLC, Lupin Limited, Prilenia Therapeutics, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Vaccinex Inc. etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. What was the size of the global Huntington's disease treatment market in 2024?
2. What is the expected growth rate of the global Huntington's disease treatment market during 2025-2033?
3. What are the key factors driving the global Huntington's disease treatment market?
4. What has been the impact of COVID-19 on the global Huntington's disease treatment market?
5. What is the breakup of the global Huntington's disease treatment market based on the type?
6. What is the breakup of the global Huntington's disease treatment market based on the drug type?
7. What is the breakup of the global Huntington's disease treatment market based on the age?
8. What is the breakup of the global Huntington's disease treatment market based on the distribution channel?
9. What are the key regions in the global Huntington's disease treatment market?
10. Who are the key players/companies in the global Huntington's disease treatment market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Huntington's Disease Treatment Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Symptomatic Treatment
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Disease-modifying Therapies
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Drug Type

7.1 Approved Drugs
- 7.1.1 Market Trends
- 7.1.2 Key Segments
  - 7.1.2.1 Tetrabenazine
  - 7.1.2.2 Deutetrabenazine
- 7.1.3 Market Forecast
7.2 Off-label Drugs
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Age

8.1 Below 50 Years
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Above 50 Years
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Drug Store and Retail Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Hospital Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Online Pharmacies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by End User

10.1 Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Homecare
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Specialty Clinics
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
10.4 Others
- 10.4.1 Market Trends
- 10.4.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

12.1 Overview
12.2 Drivers
12.3 Restraints
12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 AOP Health
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
- 16.3.2 Apotex Inc.
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
  - 16.3.2.3 SWOT Analysis
- 16.3.3 Dr. Reddy's Laboratories Ltd.
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
  - 16.3.3.3 Financials
  - 16.3.3.4 SWOT Analysis
- 16.3.4 H. Lundbeck A/S
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 Hikma Pharmaceuticals PLC
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
  - 16.3.5.3 Financials
  - 16.3.5.4 SWOT Analysis
- 16.3.6 Lupin Limited
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
  - 16.3.6.3 Financials
  - 16.3.6.4 SWOT Analysis
- 16.3.7 Prilenia Therapeutics
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
- 16.3.8 Sun Pharmaceutical Industries Limited
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Teva Pharmaceutical Industries Ltd.
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 Financials
  - 16.3.9.4 SWOT Analysis
- 16.3.10 Vaccinex Inc.
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 2,999

￦ 4,298,000

PDF & Excel (5 User License)

PDF, Excel 보고서를 동일 사업장의 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 3,999

￦ 5,731,000

PDF & Excel (Corporate License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,999

￦ 7,164,000

※ 부가세 별도

헌팅턴병 치료 시장 보고서 : 유형별, 약물 유형별, 연령별, 유통 채널별, 최종사용자별, 지역별(2025-2033년)

Huntington´s Disease Treatment Market Report by Type, Drug Type, Age, Distribution Channel, End User, and Region 2025-2033

헌팅턴병 치료 시장 동향:

본 보고서에서 다루는 주요 질문

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 주요 요약

제4장 소개

제5장 세계의 헌팅턴병 치료 시장

제6장 시장 내역 : 유형별

제7장 시장 내역 : 약물 유형별

제8장 시장 내역 : 연령별

제9장 시장 내역 : 유통 채널별

제10장 시장 내역 : 최종사용자별

제11장 시장 내역 : 지역별

제12장 촉진요인, 억제요인, 기회

제13장 밸류체인 분석

제14장 Porter's Five Forces 분석

제15장 가격 분석

제16장 경쟁 구도